We examined plasma catecholamines by ELISA, which is also one of the risk factors contribute to LVR (Supplementary Figure 6D)
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
What Patients Experience: Sudden vision loss in one or both eyes Usually painless Permanent in most cases May worsen over days to weeks The Connection: Recent studies suggest GLP-1 drugs may increase NAION risk by 2-7 times
Still, a 2022 meta-analysis exploring this link found no relationship between GLP-1 agonists and thyroid cancer or other thyroid illnesses
While Metformin improves insulin sensitivity and helps control appetite, GLP-1 medications (like semaglutide or tirzepatide) slow digestion and enhance feelings of fullness
For people living with type 2 diabetes, prediabetes, or obesity-related metabolic conditions, this is genuinely significant news